|  | |
| health | |
| NEWS | |
| UN chief praises Ebola nurses, pledges support during visit HASTINGS, Sierra Leone (Reuters) - U.N. Secretary General Ban Ki-moon on Friday praised healthcare workers fighting the Ebola virus as he paid his first visit to Liberia and Sierra Leone following an outbreak that has killed nearly 7,000 people. Ban paid ... | |
| Asthma and allergy devices 'not used properly' Patients with asthma and severe allergies are often not taught how to use their medical devices properly, charities have warned. Asthma UK said in some cases poor technique led to people being put on stronger inhalers than they actually needed. | |
| AbbVie Prices Hepatitis C Drug 12% Below Gilead Rival AbbVie Inc. (ABBV:US) and Enanta Pharmaceuticals Inc. (ENTA:US)'s hepatitis C combination drug will be about 12 percent cheaper than its rival from Gilead Sciences Inc. (GILD:US), setting the stage for fierce competition for patients of the liver virus. | |
| | |
| | |
| Infection rate penalties hit Chicago-area hospitals Northwestern Memorial Hospital in Chicago is poised to lose $1.5 million in Medicare reimbursements in 2015. The hospital's chief medical officer says the government's scoring system doesn't reward efforts to cut catheterization rates. Northwestern Memorial ... | |
| FDA approves new ovarian cancer drug Opening a new chapter in the use of genomic science to fight cancer, the Food & Drug Administration on Friday approved olaparib, a medication for advanced ovarian cancer associated with a defective BRCA gene. The new drug, to be marketed under the ... | |
| American nurse exposed to Ebola released from hospital (Reuters) - An American nurse who was exposed to Ebola while volunteering in Sierra Leone was released from the National Institutes of Health's Clinical Center in Maryland on Friday without showing signs of the disease, NIH said. "The patient has shown ... | |
| | |
| Child under observation at Chicago hospital to rule out Ebola CHICAGO (Reuters) - A child who arrived in Chicago with a fever was under observation on Friday at a city hospital to rule out the Ebola virus, hospital officials said. Federal officials screening arriving passengers at O'Hare International Airport detected the ... | |
| Half of Dr. Oz's medical advice is baseless or wrong, study says It's not hard to understand what makes Dr. Oz so popular. Called "America's doctor," syndicated talk-show host Mehmet Oz speaks in a way anyone can understand. Medicine may be complex. But with Dr. Oz, clad in scrubs and crooning to millions of viewers ... | |
| FDA OKs Cubist Antibiotic for Serious Infections The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May. Zerbaxa treats serious and resistant bacteria, such as E.coli, that can ... | |
| FDA Approves Cubist's Experimental Antibiotic Zerbaxa Cubist Pharmaceuticals Inc. 's experimental antibiotic Zerbaxa has been approved by the U.S. Food and Drug Administration for treatment of certain urinary tract infections and intra-abdominal infections. Earlier this month, Merck & Co. agreed to buy Cubist for ... | |
| | |
| Caramel apple outbreak causes illness, one death in California A multi-state listeria outbreak has resulted in five deaths and 28 cases of illness as of Dec. 18, according to a Friday release from the Centers for Disease Control and Prevention. There was one reported case of listeria in California, and that patient died, the ... | |
| | Pharmaceutical Business Review | AstraZeneca Gets FDA Approval for Ovarian Cancer Drug In what regulators called the latest advance in the development of personalized medicine, the U.S. Food and Drug Administration on Friday approved the first drug to treat cases of ovarian cancer linked to specific genetic mutations. The drug, made by ... | |
| FDA approvals boost 2 Mass. biotech firms Federal regulators Friday approved a new antibiotic to fight intra-abdominal and urinary tract infections and a three-drug cocktail to treat the liver-ravaging hepatitis C virus, giving a holiday boost to patients and to a pair of Massachusetts biotech companies. | |
| FDA approves AbbVie combo hepatitis C treatment TRENTON, N.J. (AP) - Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie. The Food and Drug Administration on Friday approved the sale of a packaged ... | |
| | North Country Public Radio | 16 North Texas hospitals lose millions in Medicare funding WASHINGTON — Texas Health Presbyterian, Medical City Dallas, Baylor University Medical Center and Parkland Memorial Hospital will lose millions of dollars in Medicare reimbursements next year because of accidents and infections acquired by patients. | |
| | Pharmaceutical Business Review | AstraZeneca cancer drug, companion test approved TRENTON, N.J. (AP) — U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC. The drug is for women whose ovarian cancer is associated with ... | |
| | |
| | |
| News of the Day From Across the Nation, Dec. 20 1 Apple deaths: Health officials are warning consumers to avoid prepackaged caramel apples after they were linked to four deaths and more than two dozen illnesses in 10 states. The CDC says it knows of 28 cases in which people were sickened with the ... | |
| Lynparza approved to treat advanced ovarian cancer FDA has approved olaparib (Lynparza, AstraZeneca) for the treatment of women with advanced ovarian cancer associated with defective BRCA genes, as determined by an FDA-approved test. FDA approved Lynparza with a genetic test called BRACAnalysis ... | |
| Ban Ki-moon visits West African countries hit by Ebola The United Nations Secretary General, Ban Ki-moon, is on a two-day visit to the West African countries worst hit by Ebola. He praised the dedication of health workers in Sierra Leone and Liberia. Mr Ban promised the UN would continue its programme of ... | |
| | |
| Ebola crisis: Top Sierra Leone doctor dies from disease One of Sierra Leone's top doctors died from Ebola hours after the arrival in the country of an experimental drug that could have been used to save him. Victor Willoughby, who tested positive for the disease only on Saturday, is the 11th doctor in the country in ... | |
| | |
| Newest HER2-Targeted Therapy No Better Than Original Agent The newest targeted therapies for HER2 breast cancer have failed to outperform the older agent that is used as a standard treatment regimen in these patients. Top-line results just released by the manufacturer, Roche/Genentech, show that its latest targeted ... | |
| New research says cavemen did not follow a paleolithic diet New research suggests that the modern take on the paleolithic is not accurate and worth the hype. Each time a new fad diet shows up on the scene there are bandwagon supporters, and there are skeptics. In the case of the paleolithic diet, supporters of the ... | |
| Patients return to Presbyterian Dallas after Ebola scare The Dallas hospital where a man died of Ebola and two nurses were infected with the disease said Friday that its revenues have returned to what they were before the crisis and patient flow is almost there. In a financial statement Friday, the parent company of ... | |
| HEALTH CARE:Hospitals fined for infection rates In determining the HAC (hospital-acquired conditions) penalties, Medicare judged hospitals on three measures: the frequency of central-line bloodstream infections caused by tubes used to pump fluids or medicine into veins; infections from tubes placed in ... | |
| Cavemen didn't stick to the caveman diet, study finds Cavemen simply ate what they could, and didn't have access to many of the hallmarks of a Paleo diet, such as bacon, eggs, and steak. Science Recorder Pro. Free trial. No ads. Exclusive interviews. Access to all articles. Just $4.99/year. Subscribe ... | |
| FDA Okays AbbVie's Viekira Pak To Treat Hepatitis C on Friday said the U.S. Food and Drug Administration has approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus genotype 1 infection, including those with a type of ... | |
| | |
| | |
| | |
| UN chief visits West African countries hardest hit by Ebola MONROVIA, Liberia -- United Nations Secretary-General Ban Ki-moon praised health workers battling Ebola in Sierra Leone and Liberia on Friday, saying they have shown "the most noble face of humankind" amid an epidemic that has killed more than 6,900 ... | |
| | |
| | North Country Public Radio | Presbyterian, UNMH hit with Medicare penalty Eleven hospitals in New Mexico, including Presbyterian and UNM hospitals in Albuquerque, will see Medicare payments cut because of the rate of hospital-acquired infections or other medical complications, according to Kaiser Health News and the U.S. ... | |
| | |
| UN chief praises Ebola healthcare workers UN Secretary General Ban Ki-moon has praised healthcare workers fighting the Ebola virus as he paid his first visit to Liberia and Sierra Leone following an outbreak that has killed nearly 7,000 people. Mr Ban paid tribute to local workers and the United ... | |
| Wild blueberries can lower bad effects of high-fat diet London: Eating wild blueberries or bilberries diminishes the adverse effects of a high-fat diet, a new study has claimed. For the first time, bilberries were shown to have beneficial effects on both blood pressure and nutrition-derived inflammatory responses, ... | |
| Pope for the Holidays The holiday season is always a good time to take stock of the year just past and see what we might anticipate in the 12 months to come. In the case of Pope Francis, it is fair to say that a great deal went well. And not only Catholics but all women and men of ... | |
| Heart drug shows potential for Ebola patients A drug currently in development for heart attack patients may be a promising treatment for Ebola. A case study, published Thursday in the journal Lancet, provides details of one doctor's successful treatment with the drug known as FX06. The 38-year-old ... | |
| Roche Says Trials of Two Drugs Have Failed Roche, the Swiss drugmaker, suffered a double blow on Friday when two clinical drug studies failed, one for breast cancer and another for Alzheimer's disease, leading to the biggest percentage drop in its stock in five years. The company said it was ending a ... | |
| Half of Dr. Oz's medical advice is baseless or wrong, study says It's not hard to understand what makes Dr. Oz so popular. Called "America's doctor," syndicated talk-show host Mehmet Oz speaks in a way anyone can understand. Medicine may be complex. But with Dr. Oz, clad in scrubs and crooning to millions of viewers ... | |
| Ebola doctor's recovery shows promise of resurrected lung drug WASHINGTON — An experimental drug that fights a condition called vascular leak may play a role in helping people survive Ebola, said doctors in Germany who used it to treat a fellow physician who contracted the virus in West Africa. Doctors at Frankfurt ... | |
| | |
| | |
| |
Receive this alert as RSS feed 
No comments:
Post a Comment